Axon Sleep Research Laboratories, Inc. – Trademark Portfolio

Entity Type: 03

Axon Sleep Research Laboratories, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. The owner is based in Newton, MA.

320 Nevada Street, 4th Floor

Newton, MA 02460

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ZEO
ZEO
Abandoned 2007
ZEO
ZEO
Cancelled 2007

Trademark Classifications

Axon Sleep Research Laboratories, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Axon Sleep Research Laboratories, Inc. have?

Axon Sleep Research Laboratories, Inc. has 3 U.S. trademarks filed with the USPTO.

What trademark classes does Axon Sleep Research Laboratories, Inc. file in?

Axon Sleep Research Laboratories, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What is Axon Sleep Research Laboratories, Inc.'s trademark registration success rate?

Axon Sleep Research Laboratories, Inc. has a 0% trademark registration rate, with 0 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.